These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 22128637)

  • 21. Lymphoma-like presentation in suspected rheumatoid arthritis due to sulphasalazine hypersensitivity syndrome.
    Shenoy P; Misra R; Jain M; Agarwal V
    N Z Med J; 2008 Jun; 121(1276):102-5. PubMed ID: 18574514
    [No Abstract]   [Full Text] [Related]  

  • 22. Toxicity profiles of disease modifying antirheumatic drugs in rheumatoid arthritis.
    Singh G; Fries JF; Williams CA; Zatarain E; Spitz P; Bloch DA
    J Rheumatol; 1991 Feb; 18(2):188-94. PubMed ID: 1673721
    [TBL] [Abstract][Full Text] [Related]  

  • 23. DRESS syndrome induced by sulphasalazine in rheumatoid arthritis.
    Bejia I; Ben Hammouda S; Riahi K; Zinelabidine F; Mediouni B; Touzi M; Bergaoui N
    Joint Bone Spine; 2006 Dec; 73(6):764-5. PubMed ID: 16626997
    [No Abstract]   [Full Text] [Related]  

  • 24. DRESS syndrome in a patient on sulfasalazine for rheumatoid arthritis.
    Michel F; Navellou JC; Ferraud D; Toussirot E; Wendling D
    Joint Bone Spine; 2005 Jan; 72(1):82-5. PubMed ID: 15681256
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Autoimmune phenomena in D-penicillamine therapy].
    Kolarz G; Ludwig H; Sabeti M; Scherak O
    Acta Med Austriaca; 1975; 2(4):130-3. PubMed ID: 1083615
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Delayed multiple injection site reaction in a rheumatoid arthritis patient treated with etanercept.
    Rajakulendran S; Deighton C
    Rheumatology (Oxford); 2004 Dec; 43(12):1588-9. PubMed ID: 15564639
    [No Abstract]   [Full Text] [Related]  

  • 27. [Pemphigus syndrome in D-penicillamine treated rheumatoid arthritis].
    Christoph R; Genth E; Grussendorf EI; Hartl PW
    Med Welt; 1978 Nov; 29(45):1761-3. PubMed ID: 152378
    [No Abstract]   [Full Text] [Related]  

  • 28. Comment on: BSR/BHPR guideline for disease-modifying anti-rheumatic drug (DMARD) therapy in consultation with the British Association of Dermatologists.
    Bhalla AK; Samaranayaka M
    Rheumatology (Oxford); 2008 Oct; 47(10):1591; author reply 1591. PubMed ID: 18676499
    [No Abstract]   [Full Text] [Related]  

  • 29. Gold vs D-penicillamine double blind study and followup.
    Thomas MH; Rothermich NO; Philips VK; Bergen W; Hedrick SW
    J Rheumatol; 1984 Dec; 11(6):764-7. PubMed ID: 6240537
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Acute generalized exanthematous pustulosis included by hydroxychloroquine during lupus].
    Fain O; Stirnemann J; Kettaneh A
    Rev Prat; 2010 Jan; 60(1):20. PubMed ID: 20222305
    [No Abstract]   [Full Text] [Related]  

  • 31. Thymoma associated with rheumatoid arthritis after D-penicillamine treatment.
    Tani K; Matsunaga K; Katoh K; Kawai T; Ueda A; Kase M; Lie JT
    Br J Rheumatol; 1998 Apr; 37(4):472-3. PubMed ID: 9619910
    [No Abstract]   [Full Text] [Related]  

  • 32. Morphea-like reaction to D-penicillamine therapy.
    Bernstein RM; Hall MA; Gostelow BE
    Ann Rheum Dis; 1981 Feb; 40(1):42-4. PubMed ID: 6451203
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Therapeutic effect of tiopronin following D-penicillamine toxicity in a patient with rheumatoid arthritis.
    Matsukawa Y; Saito N; Nishinarita S; Horie T; Ryu J
    Clin Rheumatol; 1998; 17(1):73-4. PubMed ID: 9586686
    [No Abstract]   [Full Text] [Related]  

  • 34. Toxicity to D-penicillamine in rheumatoid arthritis.
    Magnus JH; Gran JT; Mikkelsen K; Nygaard H; Brath HK
    Scand J Rheumatol; 1987; 16(6):441-4. PubMed ID: 2962277
    [No Abstract]   [Full Text] [Related]  

  • 35. [D-penicillamine-induced pemphigus, polymyositis and myasthenia].
    Jan V; Callens A; Machet L; Machet MC; Lorette G; Vaillant L
    Ann Dermatol Venereol; 1999 Feb; 126(2):153-6. PubMed ID: 10352832
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bullous pemphigoid and penicillamine.
    Weller R; White MI
    Clin Exp Dermatol; 1996 Mar; 21(2):121-2. PubMed ID: 8759198
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Salazosulfapyridine-induced hypersensitivity syndrome triggered by methotrexate.
    Teraki Y; Izaki S
    Clin Exp Dermatol; 2009 Oct; 34(7):e287-8. PubMed ID: 19438549
    [No Abstract]   [Full Text] [Related]  

  • 38. [Drug-induced exanthemas].
    Petersen CS
    Ugeskr Laeger; 2000 Dec; 162(50):6830-3. PubMed ID: 11187136
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Topical non-steroidal antirheumatic substances].
    Reiter S; Bolten W;
    Z Rheumatol; 2002 Dec; 61(6):701-2. PubMed ID: 12491135
    [No Abstract]   [Full Text] [Related]  

  • 40. Psoriasiform and pustular eruption induced by etanercept and infliximab.
    Kuhara T; Watanabe D; Iwahori Y; Tamada Y; Yamamura M; Matsumoto Y
    Eur J Dermatol; 2009; 19(4):388-9. PubMed ID: 19467963
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.